LASCCO

LASCCO SA is a biopharmaceutical technology company headquartered in Lausanne, Switzerland. The company's primary goal is to develop promising therapeutic and diagnostic products originating from research institution laboratories and advance them to the clinical trial stage. LASCCO possesses expertise and experience in the fields of intensive care and emergency medicine. Their product portfolio focuses on addressing sepsis as well as treating severe bacterial and viral infections. The company is dedicated to developing innovative treatment methods and diagnostic tools to provide better care and treatment options.